Article
CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Jun 2014
Cleven Arjen H G, Derks Sarah, Draht Muriel X G, Smits Kim M, Melotte Veerle, Van Neste Leander, Tournier Benjamin, Jooste Valerie, Chapusot Caroline, Weijenberg Matty P, Herman James G, de Bruïne Adriaan P, van Engeland Manon
Abstract excerpt
PURPOSE: Data on the prognostic significance of promoter CpG island methylation in colorectal cancer (CRC) are conflicting, possibly due to associations between methylation and other factors affecting survival such as genetic alterations and use of adjuvant therapy. Here, we examine the prognosti...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
